Loading
Invented the FOLFOX regimen that anchors colorectal chemotherapy and founded the GERCOR and ARCAD trial groups.
Aimery de Gramont (Paris) designed the infusional fluorouracil and oxaliplatin regimen known as FOLFOX, showed its benefit in the pivotal 2000 trial, and co-led MOSAIC and the IDEA collaboration on adjuvant duration. He founded the GERCOR cooperative group and the ARCAD database of pooled colorectal trials, which has reshaped endpoints and trial design in the disease.
Shares Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer (MOSAIC), Cytotoxic chemotherapy, Colorectal cancer.
Shares Colorectal cancer and the tag colorectal.
Shares Colorectal cancer and the tag colorectal.
Shares Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer (MOSAIC), Cytotoxic chemotherapy, Colorectal cancer and the tag colorectal.
Shares Cytotoxic chemotherapy and the tag cooperative-group.
Shares Cytotoxic chemotherapy, Colorectal cancer and the tag cooperative-group.
Shares Cytotoxic chemotherapy and the tag cooperative-group.
Shares Colorectal cancer and the tag colorectal.